Neha Mehta-Shah(@NehaMehtaShahMD) 's Twitter Profileg
Neha Mehta-Shah

@NehaMehtaShahMD

Lymphoma doctor, clinical researcher, associate program director; Associate Professor at Wash U in St. Louis. Views and opinions are my own.

ID:940415886401458176

calendar_today12-12-2017 02:59:54

101 Tweets

391 Followers

81 Following

Follow People
WUSM Department of Medicine(@WUDeptMedicine) 's Twitter Profile Photo

DOM Fellows’ Council will host a J-1 Waiver Panel for fellows currently on a J-1 Visa considering seeking a waiver for US employment. Led by WashU faculty & fellows that have recently gone through or in the process of a applying for a waiver.

Register> l8r.it/iudE

DOM Fellows’ Council will host a J-1 Waiver Panel for fellows currently on a J-1 Visa considering seeking a waiver for US employment. Led by WashU faculty & fellows that have recently gone through or in the process of a applying for a waiver. Register> l8r.it/iudE
account_circle
Sana Saif Ur Rehman(@SanaSaifUrRehm) 's Twitter Profile Photo

Congratulations to our very own Giulia Petrone MD and Stefan Tarnawsky MD,PhD for being selected by ASH to receive the Research Training Award for Fellows (RTAF)! 🙌🌟

So proud of you and here's to many more! WashU Heme/Onc Fellowship

Congratulations to our very own Giulia Petrone MD and Stefan Tarnawsky MD,PhD for being selected by @ASH_hematology to receive the Research Training Award for Fellows (RTAF)! 🙌🌟 So proud of you and here's to many more! @WUHemeOncFellow #ASHAwards
account_circle
Ajay Major, MD, MBA(@majorajay) 's Twitter Profile Photo

Congratulations to Rahul Bhansali, MD Stefan Barta, MD, MS, MRCP(UK) et al. on this monumental work developing the CITI score to predict CNS relapse in T/NK lymphomas, now published Blood Advances. In validation set, 13.4% incidence of CNS relapse in high risk cohort.
ashpublications.org/bloodadvances/…

Congratulations to @rsbhansaliMD @StefanBartaMD et al. on this monumental work developing the CITI score to predict CNS relapse in T/NK lymphomas, now published @BloodAdvances. In validation set, 13.4% incidence of CNS relapse in high risk cohort. #lymsm ashpublications.org/bloodadvances/…
account_circle
Neha Mehta-Shah(@NehaMehtaShahMD) 's Twitter Profile Photo

Thank you to Journal of Clinical Oncology Jonathan Friedberg for giving us the opportunity to share our two cents on how to learn from our successes and failures in TCL. Collaboration, thoughtful study designs and teamwork between all parties is key.

account_circle
Washington University in St. Louis(@WUSTL) 's Twitter Profile Photo

“With Sandro leading the way, we’re poised to elevate community health to new heights.”

We're pleased to welcome Sandro Galea, one of the world's leading public health leaders, as the inaugural Margaret C. Ryan Dean of the WashU School of Public Health. bit.ly/3xZFBon

account_circle
Neha Mehta-Shah(@NehaMehtaShahMD) 's Twitter Profile Photo

Nailed it! Each year the first year fellows impress me with their innovative studies to move the needle in cancer care. Each spring, the first year fellows present their original clinical trial concepts! Kudos to them and their dedicated mentors! 👏👏

account_circle
Graham Collins(@graham74GC) 's Twitter Profile Photo

ECHELON-3 press release: OS benefit seen
- Randomised P3 in R/R DLBCL
- BV+R2 vs R2+placebo
- Post-CAR allowed
- enrolled 'regardless of CD30 status'
Always good to see an OS advantage. BIG question here is the relevance of the control arm.

pfizer.com/news/press-rel…

account_circle
Sana Saif Ur Rehman(@SanaSaifUrRehm) 's Twitter Profile Photo

New sickle cell treatment center opens at BJC fox2now.com/news/missouri/…

So grateful for the investment and advocacy to make this dream come true!

Dedicated infusion space for patients with Sickle Cell Disease Barnes-Jewish Washington U. Med WashU Hematology

account_circle
Neha Mehta-Shah(@NehaMehtaShahMD) 's Twitter Profile Photo

I am so honored to co-chair the Ultmann Chicago Lymphoma symposium this year. The meeting was filled with wonderful discussion on how to further improve care for our patients!

Looking forward to next year!! Save the date for next year: April 4-5, 2025!

account_circle
Neha Mehta-Shah(@NehaMehtaShahMD) 's Twitter Profile Photo

Wonderful to learn from Jake Soumerai, Sarah Rutherford and Justine Kahn MD, MS today at . 🤩 Seeing your friends soar as leaders in the field makes my heart so full ❤️

Throwback to when we were baby lymphoma docs Lymphoma Research Foundation

Wonderful to learn from Jake Soumerai, Sarah Rutherford and @JustinekahnMD today at #IUCLS24. 🤩 Seeing your friends soar as leaders in the field makes my heart so full ❤️ Throwback to when we were baby lymphoma docs @lymphoma
account_circle
Neha Mehta-Shah(@NehaMehtaShahMD) 's Twitter Profile Photo

Our fellows did a tremendous job inspiring the medical students and sharing their passion for hematology/oncology at the WUSM Specialty Choice Fair. Great idea Washington U. Med WashU Heme/Onc Fellowship WashUOncology WashU Hematology

account_circle
Neha Mehta-Shah(@NehaMehtaShahMD) 's Twitter Profile Photo

Proud mentor alert! Former WashU Internal Medicine Residency Program Neha Akkad nailed her presentation on the development and validation of a CTCL specific quality of life tool across stages & a diverse population

Looking forward to expanding this effort at other centers. WashU Dermatology Amy Musiek WashUOncology

Proud mentor alert! Former @WashUIMRes Neha Akkad nailed her presentation on the development and validation of a CTCL specific quality of life tool across stages & a diverse population Looking forward to expanding this effort at other centers. @WashUDerm @amy_musiek @WashUOnc
account_circle
Neha Mehta-Shah(@NehaMehtaShahMD) 's Twitter Profile Photo

Outstanding talk by Payton Laboratory on clonal evolution in CTCL via single cell multiomics. Clonal evolution in CTCL is not linear. Data led to our study of tulmimetostat in CTCL WashUOncology

classic.clinicaltrials.gov/ct2/show/NCT05…

Outstanding talk by @Payton_Lab on clonal evolution in CTCL via single cell multiomics. Clonal evolution in CTCL is not linear. Data led to our study of tulmimetostat in CTCL @WashUOnc #WCCL classic.clinicaltrials.gov/ct2/show/NCT05…
account_circle